Opening Ceremony Time: 09:00-09:10, August 9, 2011
Keynote Forum Time: 09:10-11:20, August 9, 2011
Moderator	Dr. Xiaohu Zhang, Executive Director of Medicinal Chemistry, BioDuro-PPD, China
09:10-09:20	Chair' s Opening Remark
09:20-09:50	Title: Next Generation Medicinal Chemistry Dr. Hans-Joachim Böhm, Global Head of Chemistry & Center Manager Pharma Research Basel, Roche, Switzerland
09:50-10:20	Title: Reduction of Drug Discovery Cycle Time  through the Use of Enabling Chemistry Technologies Dr. Stevan W Djuric, Senior Director, Medicinal Chemistry Technologies and Structural Chemistry, Advanced Technology, Global Pharmaceutical Research and Development, Abbott Laboratories, USA
10:20-10:50	Title: Theravance’s Mulitvalent Approach to Dual Pharmacology: First-in-Class Clinical Candidates for Treatment of Resistant Bacteria and Respiratory Disease Dr. Dan Marquess, Vice President, Medicinal Chemistry, Theravance Inc, USA
10:50-11:20	Title: Enantiomeric Iminosugars – Small Accessible Carbohydrate Mimics Dr. George Fleet, Professor of Organic Chemistry, Chemistry Research Laboratory, University of Oxford, UK

Track 1: Biosciences and Chemical Biology & Medicinal Chemistry

Session 1-1: Molecular & Cell Biology for Medicinal Chemistry Time: 13:30-15:35, August 9, 2011 (Tuesday), Meeting Room No. 301, 3rd Floor, BICC
Chair:	Dr. Matthew Hsu, R&D Director,  Merck Millipore, USA
13:30-13:55	Keynote Speech: Title: The Selectivity Profiling of Small Molecule GPCR Compounds Using Novel Cell-based Assays Dr. Matthew Hsu, R&D Director, Merck Millipore, USA
13:55-14:20	Title: Cellular Response and Signaling Pathways to Novel Antitumor Organometallic Ruthenium Complexes Dr. Jana Kasparkova, Professor, Institute of Biophysics, Academy of Sciences of the Czech Republic; Department of Biophysics, Palacky University, Czech Republic
14:20-14:45	Title: Chemical Modifications of siRNAs to Achieve Spatiotemporal Control of Gene Expression Dr. Samit Shah, Assistant Professor, Department of Pharmaceutical Sciences, South University School of Pharmacy, USA
14:45-15:10	Title: Epigenetic Targets of Dietary Supplements Dr. Mingzhu Fang, Assistant Professor, Department of Environmental and Occupational Medicine, Environmental and Occupational Health Sciences Institute, UMDNJ-Robert Wood Johnson Medical School, USA
15:10-15:35	Title: Effect of Genetic Variation on Drug Response: The Importance of Pharmacogenomics in Personalized Medicine   Dr. Farid Menaa, Director R&D, Flurotronics Inc., USA

Session 1-2: Systems Biology, Chemical Biology and Medicinal Chemistry Time: 15:45-17:00, August 9, 2011 (Tuesday), Meeting Room No. 302, 3rd Floor, BICC
Chair	Dr. Takeshi Kimura, Corporate Executive Officer, General Manager, R&D Planning Department, Ajinomoto Co., Inc. Japan
15:45-16:10	Title: Using in Silico Studies and Physical Experiments to Advance Biomedicine from Therapeutic Peptides to DNA Sequencing Dr. Glenn J. Martyna, Professor, IBM TJ Watson Research Center and School of Physics, University of Edinburgh, USA
16:10-16:35	Title: The Potential Use of Amino Acids as a Metabolomic Subset Dr. Takeshi Kimura, Corporate Executive Officer, General Manager, R&D Planning Department, Ajinomoto Co., Inc., Japan
16:35-17:00	Title: Design and Development of ‘Guided Molecular Missiles’ for Tumor-targeting Chemotherapy Dr. Iwao Ojima, University Distinguished Professor, Stony Brook University – State University of New York, USA

Session 1-3: Bioinformatics,Chemoinformatics,Structural Biology and Medicinal Chemistry   Time: 13:30-16:20, August 10, 2011 (Wednesday), Meeting Room No. 301,3rd Floor, BICC
Chair:	Dr. Kam Y. J. Zhang, Unit Leader, Zhang Initiative Research Unit, Advanced Science Institute, RIKEN (The Institute of Physical and Chemical Research), Japan
13:30-13:55	Title: Scaffold-based Drug Design: An Efficient Tool for the Discovery of New Chemical Entities Dr. Kam Y. J. Zhang, Unit Leader, Zhang Initiative Research Unit, Advanced Science Institute, RIKEN (The Institute of Physical and Chemical Research), Japan
13:55-14:20	Title: Issues in the Structural Registration of Biopharmaceuticals Dr. Jan Holst Jensen, CEO & Founder, Biochemfusion Aps, Denmark
14:20-14:45	Title: Relationship between Topology and Selectivity for Druglike Molecules Dr. Yidong Yang, Senior Scientist of Computational Chemistry, Integrated Drug Discovery Service Business Unit, Crown Bioscience Inc. (Taicang), China
14:45-15:10	Title: Structural Changes Induced in DNA by New Platinum Drugs. Relations to Their Antitumor Activity Dr. Viktor Brabec, Professor, Institute of Biophysics, Academy of Sciences of the Czech Republic; Department of Biophysics, Palacky University, Czech Republic
15:10-15:30	Coffee Break
15:30-15:55	Title: Chloroquine Action at the Molecular Level by Means of X-ray Absorption Spectroscopy Dr. Monika Walczak, Laboratory of X-ray and Electron Microscopy Research, Institute of Physics, Polish Academy of Science, Poland
15:55-16:20	Title: HIV-1 Integrase Strand Transfer Chelating Inhibitors: A Focus on Metal Binding Dr. Emilia Fisicaro, Professor of Physical Chemistry, University of Parma, USA

Session 1-4: Pharmacokinetics and Metabolism in Drug Design Time: 08:30-09:45, August 11, 2011 (Thursday), Meeting Room No. 301, 3rd Floor, BICC
Chair:	Dr. Hongyu Zhao, Senior Scientist III, Abbott Labs, USA
08:30-08:55	Title: Discovery of Stearoyl-CoA Desaturase-1 (SCD1) Inhibitors Dr. Hongyu Zhao, Senior Scientist III, Abbott Labs, USA
08:55-09:20	Title: Carboxylesterases: A New Target for Drug-Drug Interactions? Dr. Robert B. Parker, Professor, Department of Clinical Pharmacy, University of Tennessee College of Pharmacy, USA
09:20-09:45	Title: Optimization of ADME Properties Towards Clinical Candidate Selection Dr. Kantharaj Ethirajulu, Head, Preclinical Development, S*BIO Pte Ltd, Singapore

Session 1-5: Microbiology and Medicinal Chemistry Time: 10:30-11:20, August 11, 2011 (Thursday), Meeting Room No. 301, 3rd Floor, BICC
Chair	Dr. Dianqing Sun, Assistant Professor of Pharmaceutical Sciences, College of Pharmacy, University of Hawai'i at Hilo, USA
10:30-10:55	Title: Natural Products-inspired Novel Antimicrobial Agents Dr. Dianqing Sun, Assistant Professor of Pharmaceutical Sciences, College of Pharmacy, University of Hawai'i at Hilo, USA
10:55-11:20	Title: Development of Novel Fungicides: Journey from Benchtop Science to Practical Product Dr. Cheng-Wei Tom Chang, Associate Professor, Utah State University, USA

Session 1-6: Oncology and Medicinal Chemistry Time: 13:30-17:10, August 11, 2011 (Thursday), Meeting Room No. 301, 3rd Floor, BICC
Chair:	Dr. Kinfe Ken Redda, Professor of Medicinal Chemistry and Acting, Vice President for Research, Florida A&M University, USA
Co-chair:	Dr. Ke Ding, Research Professor and Deputy Director, Institute of Chemical Biology, Guangzhou Institute of Biomedicine and Health, Chinese Academy of Sciences, China
13:30-13:50	Title: Selective Nuclear Export Modulators for Cancer: CRM1, A Novel Druggable Target for Small Molecules Dr. Vincent P. Sandanayaka, Head of Chemistry, Karyopharm Therapeutics, USA
13:50-14:10	Title: The Design and Synthesis of N-Pyridylcarbonyltetrahydropyridines as Effective Anticancer Agents Dr. Kinfe Ken Redda, Professor of Medicinal Chemistry and Acting, Vice President for Research, Florida A&M University, USA
14:10-14:30	Title: New Tumor Suppressor Gene-NDRG2 Dr. Jian Zhang, Associate Professor, The Department of Biochemistry and Molecular Biology, The Fourth Military Medical University, China
14:30-14:50	Title: The Mechanisms of Mitotic Progression and Development of Novel Anti-mitotic Cancer Therapies   Dr. Sang Hyun Lee, Assistant Professor, Duke-NUS Graduate Medical School Singapore, Singapore
14:50-15:10	Title: Cabazitaxel-Discovery and Development of a New Prostate Cancer Treatment Dr. Hervé Bouchard, LGCR / Natural Product & Protein Chemistry, Sanofi Aventis,  France
15:10-15:30	Coffee Break
15:30-15:50	Title: Identification of GZD824 as a New Kinase Inhibitor Overcoming Gleevec Clinical Resistance Dr. Ke Ding, Research Professor and Deputy Director, Institute of Chemical Biology, Guangzhou Institute of Biomedicine and Health, Chinese Academy of Sciences, China
15:50-16:10	Title: Novel Strategies in Anti-cancer Drug Discovery Dr. Shigetoshi Kadota, Professor and Director, University of Toyama, Japan
16:10-16:30	Title: The Preparation of Chiral Compounds and Their Antitumor Studies   Dr. Kim Hung Lam, Lecturer, The Hong Kong Polytechnic University, China
16:30-16:50	Title: Novel Class of Ruthenium-Therapeutic Drugs and Implications for Cancer Dr. Denise de Oliveira Silva, Professor, Institute of Chemistry, University of São Paulo, Brazil
16:50-17:10	Title: A Molecule Library Targeting Cancer Stem Cells Dr. Yue Chen, Professor, Nankai University, China

Track 2: Novel Technologies in Medicinal Chemistry

Session 2-1: Novel Technologies in Medichem Time: 08:30-11:45, August 10, 2011( Wednesday), Meeting Room No. 302, 3rd Floor, BICC
Chair:	Dr. Thomas A. Engler, Senior Research Advisor, Discovery Chemistry Research & Technologies, Lilly Research Laboratories, Eli Lilly & Company, USA
Co-chair:	Dr. Chris De Savi, Drug Discovery Leader, Oncology Innovative Medicines, AstraZeneca, UK
08:30-08:55	Keynote Speech: Title: A New Imaging Nanotechnology for Drug Development Dr. Lodewyk Kock, Professor, University of the Free State, South Africa
08:55-09:20	Title: Merging High-content Imaging, Informatics and SAR in Phenotypic Drug Discovery Dr. Thomas A. Engler, Senior Research Advisor, Discovery Chemistry Research & Technologies, Lilly Research Laboratories, Eli Lilly & Company, USA
09:20-09:45	Title: Iterative Efficiency in Medicinal Chemistry: Evolutionary Approaches to the Development of MCR Derived Scaffold Diversity Dr. Christopher Hulme, Professor of Medicinal Chemistry, Director, BIO5 Oro Valley Drug Discovery, College of Pharmacy, University of Arizona, USA
09:45-10:10	Title: General Rapid C-[11C]Methylation and C-[18F]Fluoromethylation: Revolutionary New Methodologies for the Synthesis of Short-lived PET Molecular Probes Dr. Masaaki Suzuki, Deputy Director, RIIKEN Center for Molecular Imaging Science, Molecular Imaging Medicinal Chemistry Laboratory, Japan
10:10-10:30	Coffee Break
10:30-10:55	Title: The Discovery of Highly Selective Non-Zn Binding Inhibitors of Collagenase-3 Using a Structure Based Approach Dr. Chris De Savi, Drug Discovery Leader, Oncology Innovative Medicines, AstraZeneca, UK
10:55-11:20	Title: The Cytotoxicity of Ferrocene-containg Complexes are Governed by Structural and Electrochemical Properties Dr. Jannie C. Swarts, Professor, Department of Chemistry, University of the Free State, South Africa
11:20-11:45	Title: Simplifying Analytical Work-up For the Medicinal Chemist Dr. K. K. Bhagchandani, Director of Asia & Pacific Operations, Advanced Chemistry Development, Inc. (ACD/Labs), Asia Pacific Liaison Office, India

 

 Track 3: Rational Target-based Drug Design and Synthesis

Session 3-1: New Computer-Aided Drug Design Time: 13:30-16:45, August 9, 2011(Tuesday), Meeting Room No. 303, 3rd Floor, BICC
Chair:	Dr. Yuk Sham, Professor and Assistant Director, The Center for Drug Design, University of Minnesota, USA
Co-Chair:	Dr. Tapio Atso Hase, Professor, University of Helsinki, Finland
13:30-13:55	Title: Neural Networks Based Drug Discovery Approach Dr. Guanhua Chen, Professor and Head,  Departement of Chemistry, The University of Hong Kong, China
13:55-14:20	Title: There is a New Kid in Town – Are These Topomers Really Any Good? Dr. Gunther Stahl, Director Science & Sales, PacRim, Tripos, A Certara™ Company, Germany
14:20-14:45	Title: Rational Design of HIV in Strand Transfer Inhibitors Dr. Yuk Sham, Professor and Assistant Director, The Center for Drug Design, University of Minnesota, USA
14:45-15:10	Title: Design and Synthesis of Histone Deacetylases Inhibitor Dr. Hui Zhang, Investigator, Department of Chemistry, ShenYang Medical Colleague, China
15:10-15:30	Coffee Break
15:30-15:55	Title: Structural Insights of Transient Receptor Potential Vanilloid Type 1 (TRPV1) from Homology Modeling, Docking, and Mutational Studies for the Discovery of TRPV1 Modulators Dr. Sun Choi, Professor, College of Pharmacy, Division of Life & Pharmaceutical Sciences, National Core Research Center for Cell Signaling & Drug Discovery, Ewha Womans University, Korea
15:55-16:20	Title: Design of Improved HIV Protease Inhibitors through Fragment-based and Induced-fit Docking Dr.  Art E. Cho, Professor and Chairman, Department of Bioinformatics and Biotechnology, Korea University, Korea
16:20-16:45	Title: GSK-3 Kinase as a Potential Therapeutic Target Dr. N. R. Jena, Research Scientist, Physics Department, Ravenshaw University, India

Session 3-2: Fragment-Based Drug Discovery Time: 15:55-16:45, August 9, 2011 (Tuesday), Meeting Room No. 301, 3rd Floor, BICC
Chair:	Dr. Alexander Mayweg, Head of Discovery Chemistry, Pharma Research and Early Development (pRED China), F. Hoffmann-La Roche, China
Co- Chair:	Dr. Michael H. Rabinowitz, Director, Cardiovascular Metabolic Research, Johnson & Johnson Pharmaceutical Research and Development, L.L.C., USA
15:55-16:20	Title: Fragment Based Versus Fragment Inspired Drug Discovery: Recent Trends and Perspectives Dr. Alexander Mayweg, Head of Discovery Chemistry, Pharma Research and Early Development (pRED China), F. Hoffmann-La Roche, China
16:20-16:45	Title: Structure Based Design and Biological Evaluation of Benzimidazole HIF Prolyl Hydroxylase Inhibitors for the Treatment of Anemia Dr. Michael H. Rabinowitz, Director, Cardiovascular Metabolic Research, Johnson & Johnson Pharmaceutical Research and Development, L.L.C., USA

Session 3-3: Targeting Protein-Protein Interaction Time: 08:30-09:45, August 10, 2011 (Wednesday), Meeting Room No. 301, 3rd Floor, BICC
Chair:	Dr. Kurt Deshayes, Senior Scientist, Department of Early Discovery Biochemistry, Genentech Inc., USA
08:30-08:55	Title: Disruption of Protein-Protein Interactions in the Bacterial Replisome Dr. Kathleen Turner, Team Leader, CSIRO Materials Science and Engineering, Australia
08:55-09:20	Title: Antagonizing the IAP Proteins to Induce Programmed Cell Death: Designing a New Class of Cancer Therapeutics Dr. Kurt Deshayes, Senior Scientist, Department of Early Discovery Biochemistry, Genentech Inc., USA
09:20-09:45	Title: Chemical Chaperone Therapy for Neuronogenic Lysosomal Diseases Dr. Yoshiyuki Suzuki, Research Professor, International University of Health and Welfare, Japan

Session 3-4: Targeting Ion Channels and Targeting Signaling Pathway Time: 13:30-15:10, August 10, 2011 (Wednesday), Meeting Room No. 302, 3rd Floor, BICC
Chair:	Dr. Arthur M. “Buzz” Brown, Executive Chairman & Chief Scientific Officer, ChanTest Corporation; Adjunct Professor, Physiology & Biophysics, Case Western Reserve University, USA
13:30-13:55	Title: RG3487: Preclinical Research and Early Development of a Nicotinic Alpha 7 Partial Agonist Dr. Hans Maag, Independent Consultant, Previously VP Chemistry, Roche Palo Alto, LLC, USA
13:55-14:20	Title: Screening Ion Channel Targets for Drug Safety and Discovery   Dr. Arthur M. “Buzz” Brown, Executive Chairman & Chief Scientific Officer, ChanTest Corporation; Adjunct Professor, Physiology & Biophysics, Case Western Reserve University, USA
14:20-14:45	Title: Progress in Development of the New Antiviral Agent HPMP-5-azaC and its Derivatives Dr. Marcela Krecmerova, Head of the Team “Nucleoside and Nucleotide Analogues for Biomedical Applications”, Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, Czech Republic
14:45-15:10	Title: Targeting Multiple Protein Conformations for Design of Kinase Inhibitors Dr. Jeffrey Jielou Liao, Professor, University of Science and Technology of China, China

Session 3-5: Kinases/Phosphatase Inhibitor Chemistry Time: 08:30-10:35, August 11, 2011 (Thursday),  Room No. 302, 3rd Floor, BICC
Chair:	Dr. Qun Dang, Senior Investigator, Merck & Co., Inc. USA
Co-chair:	Dr. Robin Davies, Research Director, Muscagen Limited, UK
08:30-08:55	Title: The Discovery of A-1070722: A Potent and Selective CNS-penetrant GSK-3 Inhibitor for the Treatment of Neurodegenerative and Behavioral Disorders Dr. Sean C Turner, Group Leader & Chemistry Outsourcing Head, Abbott Laboratories, USA
08:55-09:20	Title: Discovery of a Second Generation FBPase Inhibitor, MB07803, With Improved Oral Bioavailability Dr. Qun Dang, Senior Investigator, Merck & Co., Inc., USA
09:20-09:45	Title: Phosphorylase Kinase: From Biochemistry to Therapeutics Dr. Madalene Heng, Professor of Medicine/Dermatology, School of Medicine, University of California, USA
09:45-10:10	Title: Single-molecule Manipulation and Detection Platform for Studying Multitargeted Tyrosine Kinase Inhibitor PD153035 Dr. Tzu-Sen Yang, Assistant Professor, School of Dental Technology, Institute of Biomedical Materials and Engineering, Research Center for Biomedical Implants and Microsurgery Devices, Taipei Medical University, Taiwan
10:10-10:35	Title: Regulation of the GDP Kinase Mechanism within a Ligand-Receptor-G Protein Ternary Complex of the Rhodopsin Class Dr. Robin Davies, Research Director, Muscagen Limited, UK

Track 4: Lead Optimization toward Drug Candidates

Session 4-1: Drug-Like Molecules, QSAR and SAR Time: 13:30-15:35, August 9, 2011 (Tuesday), Meeting Room No. 302, 3rd Floor, BICC
Chair:	Dr. Neil Berry, Lecturer, University of Liverpool, UK
13:30-13:55	Title: Corticotropin Releasing Factor Receptor (CRF-R) Antagonist for the Treatment of Depression Dr. Xiaohu Zhang, Executive Director of Medicinal Chemistry, BioDuro-PPD, China
13:55-14:20	Title: New SMN Modulators for the Treatment of Spinal Muscular Atrophy: Discovery, SAR and Biological Properties Dr. Juan Jose Marugan, Team Leader, NIH Chemical Genomics Center, NHGRI, National Institutes of Health, USA
14:20-14:45	Title: Molecular Modelling: Novel Small Molecule Inhibitors against Malaria Dr. Neil Berry, Lecturer, University of Liverpool, UK
14:45-15:10	Title: Mass Spectrometry as a New Structural Method to Determine Small Molecule Binding to Intact Membrane Proteins Dr. Nelson P. Barrera, Assistant Professor, Department of Physiology, Pontificia Universidad Católica de Chile, Chile
15:10-15:35	Title: Antimarial properties of indolone-N-oxides Pr. Françoise Nepveu, Professor, Pharma-Dev, University of Toulouse, France

Session 4-2: Reduce Toxicity Risk and Optimize ADME/Tox: In Silico, In Vitro and in Vivo Correlation Time: 08:30-11:20, August 11, 2011 (Thursday), Meeting Room No. 303, 3rd Floor, BICC
Chair:	Dr. Jianling Wang, Head of ADME Profiling Cambridge, MAP, Novartis Institutes for Biomedical Research, USA
08:30-08:55	Title: Optimization of the Antiinfective Natural Product, Cryptolepine Dr. Seth Y. Ablordeppey, Professor and Interim Dean, College of Pharmacy & Pharmaceutical Sciences, Florida A&M University, USA
08:55-09:20	Title: Maximizing the Outcome of in Silico, In Vitro and in Vivo ADMET Tools to Win the Drug Hunting Battles Dr. Jianling Wang, Head of ADME Profiling Cambridge, MAP, Novartis Institutes for Biomedical Research, USA
09:20-09:45	Title: Guiding Decisions to Target Compounds with an Optimal Balance of Properties Dr. Matthew Segall, CEO, Optibrium Ltd, UK
09:45-10:10	Title: Role of Hepatic Transporters in the Hepatobiliary Disposition of New Chemical Entities in Discovery Dr. Guoyu Pan, Professor, Center for Drug Safety Evaluation and Research, Shanghai Institute of Materica Medica (SIMM), China
10:10-10:30	Coffee Break
10:30-10:55	Title: An Approach to Quick Lead Optimization including Physicochemical and Adme Profiling   Dr. K. K. Bhagchandani, Director of Asia & Pacific Operations, Advanced Chemistry Development, Inc. (ACD/Labs), Asia Pacific Liaison Office, India
10:55-11:20	Title: Novel Approach to Explore Antiplatelet Activity of Antihypertensive Drug  Dr. Sateesh Belemkar, Head, Department of Pharmacology, SVKM’s NMIMS, School of Pharmacy & Technology Management, India

Track 5: Biotherapeutic and Natural Product Medicinal Chemistry

Session 5-1: Natural Product Synthesis, Biology, and Structure-Function Studies Time: 08:30-11:50, August 11, 2011 (Thursday), Meeting Room No. 305 A, 3rd Floor, BICC
Chair:	Dr. William Wei-Guo Jia, VP (Research), Shanghai Innovative Research Center of Traditional Chinese, China
Co-chair:	Dr. Janine Cossy, Professor of Organic Chemistry, Laboratoire de Chimie Organique, ESPCI, France
08:30-08:50	Title: Access to Natural Products and Analogues with Antitumor Activity Dr. Janine Cossy, Professor of Organic Chemistry, Laboratoire de Chimie Organique, ESPCI, France
08:50-09:10	Title: Drug Discovery from Natural Product: From Information to Informatics Dr. William Wei-Guo Jia, VP (Research), Shanghai Innovative Research Center of Traditional Chinese, China
09:10-09:30	Title: Optimization of Interleukin-5 Anatgonist Looking for Novel Anti-asthmatic Drug Dr. Sang-Hun Jung, Professor, Chungnam National University, Korea
09:30-09:50	Title: Anti-inflammatory, Anti-cancer and Anti-viral Effects of a Nupar Lutea Extract which Inhibits NF-kB Dr. Jacob Gopas, Associate Professor, Department of Microbiology and Immunology, Faculty of Health Sciences, Ben Gurion University of the Negev and, Laboratory of Oncology, Soroka University Medical Center, Israel
09:50-10:10	Title: Phytoestrogens in Drug Discovery Dr. Kristiina Wähälä, Professor, Laboratory of Organic Chemistry, Department of Chemistry, University of Helsinki, Finland
10:10-10:30	Coffee Break
10:30-10:50	Title: Side Effect of Antidepressants Drugs on Salivar Glands and it´s Treatment Dr. Ana Maria Trindade Gregio, Pharmacology Professor, Pontifical Catholic University of Parana, Brazil
10:50-11:10	Title: A Natural Pathway Towards Drug Discovery Dr. Bhupesh Samant, Assistant Professor, Natural Product and Medicinal Chemistry (NPMC) Research Group, Division of Pharmaceutical Chemistry, Faculty of Pharmacy, Rhodes University, South Africa
11:10-11:30	Title: Isatisine A, A Potential Anti-virus Agent from Traditional Chinese Medicine Dr. Guangxin Liang, Professor, The State Key Laboratory of Elemento-organic Chemistry, Nankai University, China
11:30-11:50	Title: Glibenclamide-like Analogues: Potential Anti-hyperglycemic Compounds Dr. Fatima Regina Mena Barreto Silva, Associated Professor, Federal University of Santa Catarina, Brazil

Session 5-2: Medicinal Chemistry for Marine Natural Products Time: 10:45-12:00, August 11, 2011 (Thursday), Meeting Room No. 302, BICC
Chair:	Dr. Hendrik Luesch, Associate Professor, Department of Medicinal Chemistry, University of Florida, USA
10:45-11:10	Title: Towards Ladderane Lipids: Supramolecular Construction of Molecular Ladderanes in the Solid State Dr. Len MacGillivray, Professor, The University of Iowa, USA
11:10-11:35	Title: Potent New Anticancer Agents from Marine Cyanob Dr. Hendrik Luesch, Associate Professor, Department of Medicinal Chemistry, University of Florida, USA
11:35-12:00	Title: Anti-glioblastoma-The Breakthrough Point in Pursuing New Anticancer Drugs from Saponins? Dr. Hai-Feng Tang, Professor and Vice Director, Department of Pharmacy, Xijing Hospital, Fourth Military Medical University, China

Track 6: Drug Synthesis and Production

Session 6-1: Medicinal Chemistry for Major Disease Therapeutics Time: 09:55-11:15, August 10, 2011 (Wednesday), Meeting Room No. 301, BICC
Chair:	Dr. Sergey Vasilevskiy, Professor, Institute of Chemical Kinetics and Combustion of Siberian Branch, The Russian Academy of Sciences, Russia
Co-chair:	Dr. Ioannis N. Houpis, Senior Research Fellow, Janssen-The Pharmaceutical Division of Johnson and Johnson, API Development-Small Molecules, Belgium
09:55-10:15	Title: Click Chemistry is Convenient Tool for Preparing of Biological Active New Bioconjugates: Betulonic Acid - Heterocycles Dr. Sergey Vasilevskiy, Professor, Institute of Chemical Kinetics and Combustion of Siberian Branch, The Russian Academy of Sciences, Russia
10:15-10:35	Title: New C-Glycosylation Methodology Dr. Ioannis N. Houpis, Senior Research Fellow, Janssen-The Pharmaceutical Division of Johnson and Johnson, API Development-Small Molecules, Belgium
10:35-10:55	Title: Development of ARA-2 an Anti Depression Candidate Drug from Medichem to Process Development Dr. Wei Tian, Associate Principal Scientist, Chemical Science, Pharmaceutical Development, AstraZeneca R&D Södertälje, Sweden
10:55-11:15	Title: Polyphosphoesters - Promising Polymers for Drug Deliver Dr. Kolio Troev, Professor and Director of the Institute of Polymers, Bulgarian Academy of Sciences, Bulgaria

Track 7: Medichem R & D Outsourcing Alliance Trend

Session 7-1: Medichem R & D Outsourcing Alliance Trend Time: 11:25-12:15, August 10, 2011 (Wednesday), Meeting Room No. 301, BICC
Chair:	Dr. Ying Wang, Senior Scientist III, Abbott Laboratories, USA
11:25-11:50	Title: Effective Management of 5 year Abbott-WuXi File Enhancement Collaborations Dr. Ying Wang, Senior Scientist III, Abbott Laboratories, USA
11:50-12:15	Title: Heterocyclic Compounds with Adenosine Receptor Affinity Dr. Barbara Matuszczak, Associate Professor, Institute of Pharmacy / Pharmaceutical Chemistry, University of Innsbruck, Austria

Young Scientists Forum Time: 15:30-17:10, August 10, 2011 (Wednesday), Meeting Room No. 302, BICC
Chair:	Dr. Yong  Miao, Student, Catalysis and Solid State Chemistry, University of Lille, France
15:30-15:55	Title: Organocatalysis: A Versatile and Metal Free Strategy for the Synthesis of Polymeric Drug Delivery Devices Dr. Yong  Miao, Student, Catalysis and Solid State Chemistry, University of Lille, France
15:25-15:50	Title: Inhibition of Peptidylglycine α-amidating Monooxygenase (PAM) Dr. Feihua Cao, Student, Research School of Chemistry, Australian National University, Australia
16:20-16:45	Title: Yeast "Contraceptives" also Novel Drugs Dr. Chantel Wendy Swart, Post Doctoral Research Fellow, UNESCO-MIRCEN: Industrial Biotechnology, Department of Microbial, Biochemical and Food Biotechnology, University of the Free State, South Africa
16:45-17:10	Title: Drug Discovery Portal: an Indispensible Stride toward Lead Optimization Both in Vitro & in Vivo Dr. Qosay Al-Balas, Assistant Professor, Molecular Modeling and Drug Design, Jordan University of Science and Technology [JUST], Jordan